Original article
Cardiovascular risk assessment in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease
Evaluación del riesgo cardiovascular en la enfermedad inflamatoria intestinal asociada a la enfermedad hepática grasa metabólica
Sandra García-Mateoa,b,1,
, Samuel J. Martínez-Domíngueza,b,1, Carla J. Gargallo-Puyueloa,b, Beatriz Gallegob, Erika Alfambrab, María C. Asoa,b, Neus Martinez-Micaeloc, Nuria Amigóc,d, Javier Martínez-Garcíab,e, Pedro M. Baptistab,f, Borja Sanzg, Sara Ballestah, Judith Espinosah, Carlos Tejeroh, Fernando Gomollóna,c
Corresponding author
a Department of Gastroenterology, “Lozano Blesa” University Clinical Hospital, 50009 Zaragoza, Spain
b Aragón Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain
c School of Medicine, University of Zaragoza, 50009 Zaragoza, Spain
d Biosfer Teslab, Plaça del Prim 10, 2on 5a, 43201 Reus, Spain
e University of Zaragoza, Department of Multiscale in Mechanical and Biological Engineering, Spain
f CIBER Enfermedades Hepáticas y Digestivas (CIBERehd), 28029 Madrid, Spain
g Department of Endocrinology, Manises Hospital, 46940 Valencia, Spain
h Department of Neurology, Lozano Blesa University Hospital, 50009 Zaragoza, Spain
